Department of Genetics and Development, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.
Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA.
Cell. 2021 Feb 18;184(4):1081-1097.e19. doi: 10.1016/j.cell.2021.01.041.
Mutations in DNA damage response (DDR) genes endanger genome integrity and predispose to cancer and genetic disorders. Here, using CRISPR-dependent cytosine base editing screens, we identify > 2,000 sgRNAs that generate nucleotide variants in 86 DDR genes, resulting in altered cellular fitness upon DNA damage. Among those variants, we discover loss- and gain-of-function mutants in the Tudor domain of the DDR regulator 53BP1 that define a non-canonical surface required for binding the deubiquitinase USP28. Moreover, we characterize variants of the TRAIP ubiquitin ligase that define a domain, whose loss renders cells resistant to topoisomerase I inhibition. Finally, we identify mutations in the ATM kinase with opposing genome stability phenotypes and loss-of-function mutations in the CHK2 kinase previously categorized as variants of uncertain significance for breast cancer. We anticipate that this resource will enable the discovery of additional DDR gene functions and expedite studies of DDR variants in human disease.
DNA 损伤反应 (DDR) 基因的突变会危及基因组的完整性,并导致癌症和遗传疾病。在这里,我们使用依赖于 CRISPR 的胞嘧啶碱基编辑筛选,鉴定出了超过 2000 个 sgRNA,这些 sgRNA 会在 86 个 DDR 基因中产生核苷酸变异,导致细胞在 DNA 损伤后适应性改变。在这些变体中,我们发现 DDR 调节因子 53BP1 的 Tudor 结构域中的失活和功能获得性突变体,定义了一个非典型的表面,该表面对于结合去泛素化酶 USP28 是必需的。此外,我们还鉴定了 TRAIP 泛素连接酶的变体,这些变体定义了一个结构域,其缺失会使细胞对拓扑异构酶 I 抑制剂产生抗性。最后,我们鉴定了 ATM 激酶的突变,这些突变具有相反的基因组稳定性表型,以及 CHK2 激酶的失活突变,后者之前被归类为乳腺癌意义不明的变体。我们预计,这一资源将能够发现更多的 DDR 基因功能,并加速对人类疾病中 DDR 变体的研究。